- Home
- ONC vs BBDO Comparison
ONC vs BBDO Comparison
Compare ONC & BBDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONC | BBDO |
|---|---|---|
| Founded | 2010 | 1943 |
| Country | Switzerland | Brazil |
| Employees | 12000 | 82095 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 33.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONC | BBDO |
|---|---|---|
| Price | $309.60 | $3.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $374.75 | N/A |
| AVG Volume (30 Days) | ★ 187.3K | 68.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $747.23 | $70.95 |
| Revenue Next Year | $15.78 | $8.23 |
| P/E Ratio | $614.06 | ★ $9.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $227.40 | $2.00 |
| 52 Week High | $385.22 | $3.77 |
Technical Indicators
Market Signals| Indicator | ONC | BBDO |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 62.92 |
| Support Level | $307.93 | $2.86 |
| Resistance Level | $320.35 | $3.76 |
| Average True Range (ATR) | 7.68 | 0.12 |
| MACD | 4.77 | 0.05 |
| Stochastic Oscillator | 82.89 | 94.34 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.